PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Plazomicin→

Plazomicin PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
1154757-24-0
PubChem CID
42613186
Molecular formula
C25H48N6O10
Molecular weight
592.7 g/mol
Drug class
Aminoglycoside antibacterial agent
Mechanism of action
Binds to the bacterial 30S ribosomal subunit and inhibits protein synthesis, producing concentration-dependent bactericidal activity against susceptible Enterobacteriaceae.
Indications / reported uses
  • Treatment of adults with complicated urinary tract infection, including pyelonephritis, caused by designated susceptible Enterobacteriaceae when limited or no alternative treatment options are available, under the product label.

Sources: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1243fcd3-de84-428b-901e-d83d65e4d98c · https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=0b82ffed-27f4-4f5c-8135-670c148f0e12

Identification source: PubChem record (CID 42613186). The linked PubChem record is provided for identity reference. Confirm the exact salt, hydrate, isomer, mixture, or product form against authoritative source documentation when defining the assessment scope.

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Plazomicin PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Plazomicin Permitted Daily Exposure (PDE) report (the Plazomicin PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Plazomicin Occupational Exposure Limit (OEL) report (the Plazomicin OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.